Cahill Logo

Firm News

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com

Valeant Completes Amendment to Credit Facility

Date: 02/13/12

Cahill represented the arrangers and administrative agent in connection with a $600,000,000 Tranche B Term Loan Facility for Valeant Pharmaceuticals International, Inc. The loan will be added to the existing $2.5 billion credit facility comprised of a $1,225,000,000 Term A loan, a $275,000,000 revolving credit facility, a $500,000,000 delayed draw term loan and a $500,000,000 Incremental Term Loan Facility. Proceeds will be used to refinance existing indebtedness, finance acquisitions, and for general corporate purposes.

Julie Cohen
Director of Marketing and Communications
212.701.3614
jcohen@cahill.com